189 related articles for article (PubMed ID: 12210046)
1. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.
Hugger ED; Novak BL; Burton PS; Audus KL; Borchardt RT
J Pharm Sci; 2002 Sep; 91(9):1991-2002. PubMed ID: 12210046
[TBL] [Abstract][Full Text] [Related]
2. Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers.
Hugger ED; Audus KL; Borchardt RT
J Pharm Sci; 2002 Sep; 91(9):1980-90. PubMed ID: 12210045
[TBL] [Abstract][Full Text] [Related]
3. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
Rege BD; Kao JP; Polli JE
Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
[TBL] [Abstract][Full Text] [Related]
4. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory Effects of Commonly Used Excipients on P-Glycoprotein in Vitro.
Gurjar R; Chan CYS; Curley P; Sharp J; Chiong J; Rannard S; Siccardi M; Owen A
Mol Pharm; 2018 Nov; 15(11):4835-4842. PubMed ID: 30350641
[TBL] [Abstract][Full Text] [Related]
6. In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam.
Bravo González RC; Huwyler J; Boess F; Walter I; Bittner B
Biopharm Drug Dispos; 2004 Jan; 25(1):37-49. PubMed ID: 14716751
[TBL] [Abstract][Full Text] [Related]
7. Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes.
Shono Y; Nishihara H; Matsuda Y; Furukawa S; Okada N; Fujita T; Yamamoto A
J Pharm Sci; 2004 Apr; 93(4):877-85. PubMed ID: 14999725
[TBL] [Abstract][Full Text] [Related]
8. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter.
Sawangrat K; Yamashita S; Tanaka A; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
J Pharm Sci; 2019 Mar; 108(3):1315-1325. PubMed ID: 30389568
[TBL] [Abstract][Full Text] [Related]
10. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.
Friche E; Jensen PB; Sehested M; Demant EJ; Nissen NN
Cancer Commun; 1990; 2(9):297-303. PubMed ID: 1976341
[TBL] [Abstract][Full Text] [Related]
11. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
Tang F; Horie K; Borchardt RT
Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.
Tang F; Ouyang H; Yang JZ; Borchardt RT
J Pharm Sci; 2004 May; 93(5):1185-94. PubMed ID: 15067695
[TBL] [Abstract][Full Text] [Related]
13. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion.
Li M; Si L; Pan H; Rabba AK; Yan F; Qiu J; Li G
Int J Pharm; 2011 Jan; 403(1-2):37-45. PubMed ID: 20969937
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function.
Komarov PG; Shtil AA; Buckingham LE; Balasubramanian M; Piraner O; Emanuele RM; Roninson IB; Coon JS
Int J Cancer; 1996 Oct; 68(2):245-50. PubMed ID: 8900436
[TBL] [Abstract][Full Text] [Related]
15. Automated analysis of polyethylene glycol-induced inhibition of P-glycoprotein activity in vitro.
Hugger ED; Cole CJ; Raub TJ; Burton PS; Borchardt RT
J Pharm Sci; 2003 Jan; 92(1):21-6. PubMed ID: 12486678
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and Caco-2 cell monolayers.
de Souza J; Benet LZ; Huang Y; Storpirtis S
J Pharm Sci; 2009 Nov; 98(11):4413-9. PubMed ID: 19472342
[TBL] [Abstract][Full Text] [Related]
17. Inhibition mechanism of P-glycoprotein mediated efflux by mPEG-PLA and influence of PLA chain length on P-glycoprotein inhibition activity.
Li W; Li X; Gao Y; Zhou Y; Ma S; Zhao Y; Li J; Liu Y; Wang X; Yin D
Mol Pharm; 2014 Jan; 11(1):71-80. PubMed ID: 24256068
[TBL] [Abstract][Full Text] [Related]
18. The effect of polyoxyethylene polymers on the transport of ranitidine in Caco-2 cell monolayers.
Ashiru-Oredope DA; Patel N; Forbes B; Patel R; Basit AW
Int J Pharm; 2011 May; 409(1-2):164-8. PubMed ID: 21382460
[TBL] [Abstract][Full Text] [Related]
19. Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20.
Weiszhár Z; Czúcz J; Révész C; Rosivall L; Szebeni J; Rozsnyay Z
Eur J Pharm Sci; 2012 Mar; 45(4):492-8. PubMed ID: 21963457
[TBL] [Abstract][Full Text] [Related]
20. The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison.
Weinheimer M; Fricker G; Burhenne J; Mylius P; Schubert R
Eur J Pharm Sci; 2017 Oct; 108():13-22. PubMed ID: 27590127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
